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Abstract
It is well-established that for a considerable period the United Kingdom has spent proportionally less of its 
gross domestic product (GDP) on health-related services than almost any other comparable country. Average 
European spending on health (as a % of GDP) in the period 1980 to 2013 has been 19% higher than the United 
Kingdom, indicating that comparable countries give far greater fiscal priority to its health services, irrespective 
of its actual fiscal value or configuration. While the UK National Health Service (NHS) is a comparatively lean 
healthcare system, it is often regarded to be at a ‘crisis’ point on account of low levels of funding. Indeed, many 
state that currently the NHS has a sizeable funding gap, in part due to its recently reduced GDP devoted to 
health but mainly the challenges around increases in longevity, expectation and new medical costs. The right 
level of health funding is a political value judgement. As the data in this paper outline, if the UK ‘afforded’ the 
same proportional level of funding as the mean average European country, total expenditure would currently 
increase by one-fifth. 
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Background 
As one introductory text on social policy states “…the amount 
governments spend on social policy can go up or down, 
depending on changing priorities.”1 While some countries 
do not exercise complete control over social spending, recent 
political campaigns in the United Kingdom that have pledged 
to increase2 or decrease3 social spending indicate that levels of 
economic input reflect changing priorities.
On this basis, funding levels are one proxy of establishing the 
commitment of governments to social spending. Allowing for 
relative comparisons, this is commonly explored and expressed 
by establishing what proportion of gross domestic product 
(GDP) a country spends.1,4-6 While it is well-established that 
the UK government, when compared to other comparable 
countries, has for a long time spent a smaller proportion on 
and prioritised less of its GDP to health-related services,4-7 a 
critical question in proportional terms is by how much? 
Why is this an important issue? The priorities of governments 
is an important area to investigate. All Western countries 
face similar challenges in relation to increases in longevity, 
expectation and new medical costs.8-10 However, in the 
United Kingdom, there are particular concerns about 
funding shortfalls for the National Health Service (NHS).7 
Despite being one of the most cost-effective health systems 
in reducing adult mortality11 there are frequent indirect and 
direct concerns and dissatisfaction around whether levels of 
NHS funding can sustain the high quality to which it aspires. 
One example of an indirect dispute, but inextricably linked to 
levels of resources, concerns the recent junior doctors strike, 
while a more direct concern is epitomised by the excess of 
deaths in the Mid Staffs NHS Trust, which caused a national 
scandal. The resulting inquiry, the Francis Report, indicated 
that it was a distinct possibility that the trust “…did not have 
the resources and ability and failed to alert those responsible 
to the problem.”12 Reflecting these concerns, the retiring NHS 
Chief Executive Sir David Nicholson stated that it was “pretty 
clear in the NHS that there is a substantial financial problem, 
particularly in the hospital sector.”13 Recent financial results 
supports these concerns. In the first half of the 2015-2016 
financial year the NHS had a £1.6bn deficit, with a £2.2bn 
deficit forecast for the end of the financial year.14 
Amid the above concerns to the health and ability of the system 
to cope with increased demand, and such is the perceived need 
for extra funding, in November 2015 the UK government 
pledged an extra £3.8bn – or around a 4% increase on NHS 
England’s £101bn front line budget. This was reported to be 
part of the wider commitment for an increase in the annual 
NHS budget of £8bn by 2020.15 Yet, recent analysis outlines 
that even these increases will fall short of adequately filing 
gaps in funding.7 
As Mladovsky and colleagues outline, much of the political 
rhetoric and media narrative in the United Kingdom rarely 
highlights successes of the system and instead focuses on 
how the current configuration of services is unsustainable, 
running out of money and unaffordable.5 The economic input 
of any system can only be based on what can be afforded. 
The recent pledge by the ‘leave’ campaign to increase NHS 
funding by £350m per week upon Britain’s exit from the 
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European Union (EU) indicates that an increase in funding 
may only be possible by de-prioritising other areas (though 
at the time of writing this pledge has been reneged). Indeed, 
as Appleby suggests, historically increases in NHS spending 
has been done by de-prioritising other areas of public policy.16 
But, crucially, does the United Kingdom prioritise and ‘afford’ 
as much as other comparable countries?
The Blair government in the United Kingdom once outlined 
that, in order to meet the aforementioned challenges, a worthy 
policy objective should be to bring proportional health 
expenditure in line with the European average.17 Revisiting 
this proposal in the context of the contemporary concerns 
raised since (some of which are outlined above), what current 
additional proportional commitment would the United 
Kingdom need to make in order to reflect the proportional 
commitment made by comparable European countries?
Before addressing this question, it is important to be clear 
with the boundaries of what it is possible to claim, particularly 
in light of the configuration of different healthcare systems. 
When making national comparisons around fiscal priority in 
relation to health-related services, it must be acknowledged 
that the public-private configuration of health systems differs. 
On this basis, proportional comparisons around national fiscal 
commitments on health-related services must encompass 
whole systems (as opposed to isolating public expenditure), 
regardless of configuration. 
While this whole systems approach provides a more robust 
and overall analysis, it triggers a question in the United 
Kingdom context around whether a low level of fiscal priority 
can solely be attributable to low levels public spending 
alone (and not low levels of private expenditure), and thus, 
whether it is reasonable to highlight and or call for increased 
public expenditure. While this may be a political question, 
it can be addressed robustly by examining attitudes towards 
healthcare configuration. This can determine whether there 
is a substantial desire for people to privately fund their own 
healthcare and, by implication, if it is credible to suggest low 
levels of funding could be made up from private sources.
The NHS continues to be held in high regard by the British 
public, with 89% of respondents to a large British Social 
Attitudes survey supporting the principle of publicly funded 
healthcare through taxation and free at the point of use.18 
Although reforms for nearly three decades have sought 
to allow private and third sector agencies to provide NHS 
funded services,19 in contrast, only approximately only 13% 
of UK citizens have solely private medical insurance.20 The 
high regard that the NHS has in public consciousness, and 
relatively low level of purely private coverage, suggests it is 
not credible to position private sources as making up any 
shortfall. Thus, it is reasonable to indicate from a political and 
public perspective that any increase in priority around health-
related expenditure should come from public and not private 
sources.
Methods
Cross-referencing the percentage of comparable western 
countries gross-domestic-product expenditure on health 
(GDPEH) gives an indication of what priority and proportion 
of national income countries prioritise to funding health-
related services. An Organization for Economic Co-operation 
and Development (OECD) dataset exists that illustrates 
different national GDPEH.21 However, it has many breaks on 
account of differences in methodology and even estimated 
values. However, more robust data is openly available.
The US Bureau of Statistics22 and The World Bank23 provide 
data on countries GDPEH from 1980 to 2013. Countries are 
ranked in Table by the highest average of GDPEH over the 
period and includes all sources of health-related funding 
from both public and private sources. The GDPEH average 
for 1980 up to 2013 comes from 24 separately reported years. 
Five countries did not have data for every year, and missing 
years are indicated in the table. 
With the majority of expenditure coming from government 
sources in the United Kingdom, and questions of public 
spending, and thus, by implication healthcare spending, 
are issues that cannot be detached from politics.24 On this 
basis, the GDPEH results are grouped into three phases that 
cover different UK government periods of office (1980-1997, 
1998-2010, and 2010-2013). Averages for these periods and 
overall averages are calculated to compare UK GDPEH with 
other comparable European countries. Ratios are also used 
to illustrate proportional differences in relation to GDPEH 
between the United Kingdom and European countries. The 
Unites States was not included in any meaningful comparisons 
as its very high GDPEH would distort any findings in 
comparison to the United Kingdom, hence the creation of a 
UK to Europe GDPEH ratio is a more modest comparison.
Limitations
Two aspects should be noted in relation to the clarity and 
limitations of this methodology. Firstly, although directly 
stated, the percentage differences in spending is not the 
core focus of this article. Instead the article focuses on the 
percentage difference in the priority and proportion of GDP 
spent on health. Secondly, and in relation to this, although 
each percentage national expenditure differs in amount (and 
thus, has a different numerator and denominator), calculating 
averages and using ratios serves to approximate proportional 
differences, as opposed to accurately represent them. 
Results
The UK’s GDPEH in 1980 was 5.6% and ranked 19th out of the 
21 countries for which data is available. By 1997 UK GDPEH 
rose to 6.7%, but was the lowest of the 21 countries. Over the 
period 1980-1997, UK GDPEH averaged 6.2%, or was ranked 
20th out of the 21 countries listed. In the same period, the 15 
other European countries averaged 7.7%, equating to a UK 
to Europe ratio of 1: 1.24. On this basis, as a percentage of 
GDP, European countries average healthcare expenditure was 
proportionally 24% higher than the United Kingdom.
From 1998 to 2010, UK GDPEH went from 6.7% to 9.4%. 
For the United Kingdom, 1998 to 2010 was the highest 
ever GDPEH commitment, averaging 7.9% over the period, 
compared to the European average of 9.1%. This yields a 
UK to Europe ratio of 1.1.15, or in other words, European 
countries average healthcare expenditure was 15% higher 
than the United Kingdom as a % of GDP.
Over the final period from 2010-2013, UK GDPEH went 
from 9.4%, down to 9.2% in 2011, rose to 9.3% in 2012 and 
then decreased to 9.1% in 2013. On this basis, the UK average 
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over the period was 9.2%. When compared to the European 
average of 10.3%, this data yields UK to European ratio of 
1: 1.12, indicating that recently European countries average 
healthcare expenditure was 12% higher than the United 
Kingdom as a % of GDP during the period.
Over the whole period of 1980-2013, the UK GDPEH relative 
to other countries rose and fell but its overall average of 6.9% 
is the lowest in the GDPEH league table, followed by Spain at 
7% and 7.2% for Greece and Japan.
Though the United Kingdom has narrowed the gap, which is 
attributable to the increases in proportional spending by the 
Blair government, recent years have seen UK GDPEH flat line. 
In other words, where once the United Kingdom was catching 
up, recent years indicate the proportional commitment –
relative to comparable European countries – is beginning to 
widen again.
The European average for the whole 1980-2013 period of 
8.2% yields a UK to Europe ratio of 1: 1.19, thus, average 
European spending on healthcare as a % of GDP in the 
period 1980 to 2013 has been approximately one-fifth higher, 
indicating a substantially greater priority given to its health 
services, irrespective of its real fiscal value or configuration. 
Interestingly, and of note, over the period the United States 
had the highest GDPEH, increasing from 9.0% in 1980 to 
17.1% in 2013. The United States 1980-2013 average is 12.4%, 
equating to a UK to US ratio of 1: 1.80. Thus comparatively, the 
United States afforded approximately 80% more to healthcare 
expenditure than the United Kingdom as a % of GDP. 
Finally, it should be noted that, although every country 
increased its GDPEH considerably over the period, in 
some years a country reduced its level compared with the 
immediate preceding year. For example, the UK rate fell from 
the previous year’s level in 1984, 1985, 1987, 1994, 1995, 2011, 
and 2013. 
Discussion 
With the most recent data illustrating the GDPEH 
commitment for 2013, this paper does not take into account 
the extra £3.8bn annual increase pledged for England in 
November 2015 or the extra £8bn a year to be committed from 
2020.15 However, considering that there are over 140 English 
NHS providers for whom this money will be apportioned 
by NHS England, these increases are modest. Indeed, recent 
analysis outlines that these increases will still equate to a 
funding shortfall.7
Clearly in terms of commitment and priority to health funding, 
compared to other Western countries, over this period of over 
30 years the United Kingdom is the least fiscally committed in 
the developed world. The fact that Britain’s GDPEH fell from a 
high of 2010, at 9.4% and fell in 2011 and 2013, down to 9.1%, 
perhaps reflects the wider and primary fiscal aim of austerity, 
ie, the well-publicised ambition to reduce the deficit. Hence, 
less of the rising national income, GDP, is being devoted to 
health than was previously.
Though partly attributable to low levels of spending, recent 
research finds that the NHS is regarded as the most efficient 
and cost-effective healthcare systems in the world.5 More 
specifically, in reducing adult (55-74) total mortality and 
cancer deaths, the United Kingdom had the second biggest 
reduction in 20 years and was one of the most cost-effective 
systems in the world.25,26 In addition, the United Kingdom met 
the UN Millennium goal of reducing child mortality, proving 
Table. % GDPEH 1980 -2013 (% Rounded-up) 




















1. USA 9.0 13.9 9.9 14.0 17.1 16.4 17.1 17.1 12.4
2. Germany 8.4 10.7 8.8 10.6 11.6 10.7 11.3 11.3 9.5
3. France 7.0 9.9 8.8 9.6 11.6 10.4 11.7 11.6 9.4
4. Switzerland 7.3 10.2 8.5 10.4 10.9 10.8 11.5 11.3 9.4
5. Canada 7.0 9.3 9.0 9.3 11.1 9.8 10.9 10.9 9.3
6. The Netherlands 7.4 8.5 8.3 8.7 12.1 9.4 12.9 12.6 8.7
7. Sweden 8.9 8.6 8.6 7.9 9.5 8.8 9.7  9.6 8.7
8. Austria 7.4 8.4 8.0 8.4 11.1 9.4 11.0 11.0 8.5
9. Belgium 6.3 7.9 7.4 8.6 10.6 9.7 11.0 10.5 8.2
10. Norway 7.0 7.5 7.5 8.6 9.4 8.7 9.6 9.4 8.0
11. Italy 7.0 7.6 7.6 7.7 9.4 8.4 9.1 9.2 7.9
12. Australia 6.1 8.4 7.6 8.6 8.9 8.4 9.0 9.0 7.9
13. Denmark 8.9 8.1 7.1 8.3 11.1 9.0 10.6 10.8 7.8
14. New Zealand 5.9 7.6 7.1 8.6 10.0 8.6 9.7 10.0 7.7
15. Finland 6.3 7.7 7.7 7.4 9.0 7.7 9.4 9.1 7.7
16. Portugal 5.3 7.9 6.7 6.4 10.9 8.8 9.7 10.0 7.4
17. Ireland 8.2 7.0 7.3 6.9 9.2 7.3 8.9 8.9 7.3
18. Japan 6.5 7.2 6.7 7.5 9.6 8.0 10.3 10.2 7.2
19. Greece 5.9 8.6 6.1 8.4 9.5 9.1 9.8 9.6 7.2
20. Spain 5.3 7.4 6.5 6.6 9.6 7.9 8.9 9.5 7.0
21. UK 5.6 6.7 6.2 6.7 9.4 7.9 9.1 9.2 6.9
Europe average 7.0 8.5 7.7 8.5 10.5 9.2 10.4 10.4  8.2
UK’s rank 19th 21st 20th 19th 17th 18th 18th 18th  21st
UK:EU ratio 1: 0.84 1.25 1.27 1.24 1.27 1.12 1.16 1.14 1.13 1.19
Abbreviations: GDPEH, gross-domestic-product expenditure on health; GDP, gross domestic product.
Correlating Rank Total GDPEH vs. Highest Public GDPEH Rho = +0.3906, P < .05.
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to be the eighth most cost-effective of Western countries.27 
In other words, in these key areas the health services in the 
United Kingdom still achieves proportionally more with 
comparatively less. 
In contrast to much political rhetoric and media narrative 
that focuses on the UK system as being unsustainable and 
unaffordable,5 it is important to state unequivocally that the 
aforementioned figures can be seen as a vindication for the 
UK model of predominately publicly funded health (‘free at 
the point of use’ but funded mainly through taxation). On this 
basis, considering the effectiveness of the UK health system in 
relation to current economic input, and to counter the main 
position put forward in this paper and by others,5 the question 
must be asked whether there is actually a feasible a case to 
increase expenditure, possibly in line with the proportional 
commitments made European countries?
With many factors to consider, it is often not particularly 
helpful to refer to a health system as a single entity. Health 
systems have many components and are complex. Delving 
deeper, a case can be made that the aforementioned figures 
do not provide a full indication of system health status. 
In addition, despite the aforementioned clinical achievements, 
as outlined earlier many NHS local Trust providers are 
currently running a large deficit which are forecast to increase 
further.14 This funding gap, according to a former NHS Chief 
Executive, will mean that NHS providers will struggle to meet 
the challenges of increased longevity and rising healthcare 
expectations faced by every Western country.13 
Clearly then, there is a case to increase UK GDPEH. Yet, 
it is also important to note that increasing the financial 
commitment to healthcare is not necessarily a guarantee of 
using funds efficiently or effectively. Although inextricably 
linked, any recommendations are beyond the remit of this 
paper.
Conclusion
By a significant margin, the UK commits proportionally less of 
national income than all other comparable western countries. 
Furthermore, this is not a recent phenomenon brought on by 
contemporary austerity measures. Rather, the data outlines 
that this proportionally low level of financial commitment is 
an entrenched and established historical trend. 
Many NHS providers are currently in deficit and financial 
difficulty.14 The data in this paper outlines that the fiscal context 
in which NHS providers operate is one, when compared to 
other European countries, of relative disadvantage. 
But what is the right level of commitment? As noted 
elsewhere, to some extent this question is a political value 
judgement.4 However, if the United Kingdom had prioritised, 
afforded and committed the same proportional level of 
funding as the average European country, current total 
expenditure for the United Kingdom would be around one-
fifth higher. In the context of current and forecasted funding 
shortfalls in the NHS,7 an increase in funding to the European 
average would begin to address funding shortfalls. Echoing 
others16 who have recently contributed to discussion in 
this area, if other comparable countries can make a larger 
proportional commitment and deem it affordable, in light of 
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